Atlas Trials

Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1

Clinical trial NCT02122952 · COMPLETED

Trial details

NCT number
NCT02122952
Sponsor
Novartis Gene Therapies
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Spinal Muscular Atrophy 1
Start date
2014-05-05
Primary completion
2017-12-15
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.